Amplitude Surgical - 1st Half-year 2024-25: Consolidated Sales of €51.5m, +6.3% at Constant Exchange Rates
21 2월 2025 - 2:00AM
Business Wire
- Consolidated sales of €51.5 million, up+ 6.3% at constant
exchange rates
- Good sales growth in France at +4.6%
- Strong growth in international business thanks to subsidiaries,
with sales up +12.6% at constant exchange rates
Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME
eligible), the French market leader in surgical technologies for
lower limb orthopedics, announces its consolidated sales for the
first half of the 2024-25 financial year.
Olivier Jallabert, Chief Executive Officer of Amplitude
Surgical, comments: "In the first half of the 2024-25 financial
year, Amplitude Surgical continued its good momentum following the
previous financial year, posting growth of +6.3% at constant
exchange rates compared with the first half of 2023-24. This good
performance was achieved thanks to growth in the activity of
international subsidiaries (+12.6% at constant exchange rates) and
the continuation of the good level recorded in France of
+4.6%."
Consolidated sales for 1st half 2024-25
Sales H1
2024-25
31/12/2024
31/12/2023
Change at current exchange
rates
Change at constant exchange
rates
In K€ - IFRS
Knee and hip activities
51,503
49,056
5.0%
6.3%
Total
51,503
49,056
5.0%
6.3%
Sales Q2
2024-25
31/12/2024
31/12/2023
Change at current exchange
rates
Change at constant exchange
rates
In K€ - IFRS
Knee and hip activities
29,750
28,550
4.2%
5.3%
Total
29,750
28,550
4.2%
5.3%
In the first half (July-December 2024) of the 2024-25 financial
year, Amplitude Surgical sales came to €51.5 million, up +5.0% and
+6.3% at constant exchange rates.
Knee and hip business grew in France by +4.6% and
internationally by +10.4% at constant exchange rates. Within the
international scope, international distributors were up +3.8%, and
the Group's international subsidiaries recorded a +6.7% increase at
current exchange rates, and a +12.6% increase at constant exchange
rates.
Amplitude Surgical's direct sales (French market and
international subsidiaries), which account for almost 93% of total
Group sales, rose by +6.4% at constant exchange rates.
In France, the Group continued to grow as in the previous year.
France accounted for around 71% of Group sales in the first half of
the 2024-25 financial year.
International subsidiaries reported growth at constant exchange
rates in Belgium, Australia, Brazil and South Africa, while sales
in Germany and Switzerland were down.
Next press release:
Half-year results 2024-25: Wednesday, March 26, 2025, after
market close.
About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a
leading French player in the global market for surgical
technologies for lower limb orthopedics. Amplitude Surgical
develops and markets high-end products for orthopedic surgery,
covering the main pathologies affecting the hip and knee. Working
in close collaboration with surgeons, Amplitude Surgical develops
numerous high value-added innovations to best meet the needs of
patients, surgeons and care facilities. A leading player in France,
Amplitude Surgical is expanding internationally through its
subsidiaries and a network of agents and exclusive distributors in
over 30 countries. As of June 30, 2024, Amplitude Surgical employed
428 people and generated sales of nearly 106.0 million euros.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250220756589/en/
Amplitude Surgical Dimitri Borchtch Chief Financial
Officer finances@amplitude-surgical.com 04 75 41 87 41
NewCap Investor Relations Thomas Grojean
amplitude@newcap.eu 01 44 71 94 94
NewCap Media Relations Nicolas Merigeau
amplitude@newcap.eu 01 44 71 94 98
Amplitude Surgical (EU:AMPLI)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Amplitude Surgical (EU:AMPLI)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
